Introduction: Telepresence surgery offers theoretically to overcome two main problems of laparoscopic surgery, i.e. the limitation to only four degrees of freedom and the lack of stereovision. Since 1998, telesurgical minimally invasive procedures have been performed with the da Vinci system mainly for cardiac bypass surgery. Clinical experience in urology is still very limited. We want to present our initial experience using the device for robot–assisted laparoscopic radical prostatectomy. Material and Methods: The Intuitive surgical system consists of two main components: the surgeon’s viewing and control console with 3D imaging and the surgical arm unit that positions and maneuvers detachable surgical instruments. These instruments introduced via two 8–mm trocars allow movements in all 6 degrees of freedom due to the EndoWrist technology. The surgeon performs the procedure seated at the console holding specially designed instruments. Highly specialized computer software and mechanics transfer the surgeon’s hand movements exactly to the microsurgical movements of the manipulators at the operative site. We have used a semilunar–shaped 5–trocar arrangement with the robot’s arms at the lateral trocars and two assistant trocars medially. A sixth trocar was used in the right suprapubic area for retraction of the gland. The left assistant used different instruments such as bipolar forceps, Ultracision, Endoclip, whereas the right assistant mainly used the suctcion–irrigation device. Except the first case, the Intuitive System was attached after exposure of Retzius’ space. Results: We have treated 6 patients (2 pT2, 4 pT3, median Gleason score 6). The OR time averaged 315 (242–480) min including pelvic lymph node dissection. No intraoperative complications occurred, 1 patient required transfusions. There were no positive margins, median catheter time was 5 days. 3 patients were completely continent after 1 month. Conclusion: Telerobotic laparoscopic surgery offers several advantages over all presently available techniques, such as all six degrees of freedom, dexterity enhancement, tremor filtering, and stereovision. There is a learning curve with the device, mainly because of the magnification, the 3D image and the lack of tactile feedback. However, only after a short period of time, the experienced surgeon is able to get familiar with the device. However, there are still concerns with respect to the high investment and running costs of the device as well as regarding the necessitity of further developments of instruments for urological procedures.

Keywords:
Laparoscopy, Radical prostatectomy, Telesurgery, Robotics
1.
Guillonneau B, Vallancien G: Laparoscopic radical prostatectomy: The Montsouris experience. J Urol 2000;163:418–422.
2.
Frede T, Stock C, Renner C, Budair Z, Abdel–Salam Y, Rassweiler J: Geometry of laparoscopic suturing and knotting techniques. J Endourol 1999;13:191–198.
3.
Green PE, Piantanida TA, Hill JW, Simon IB, Satava RM: Telepresence: Dexterious procedures in a virtual operating field (abstract). Am Surg 1991;57:192.
4.
Satava RM: Robotics, telepresence and virtual reality: A critical analysis of the future of surgery. Min Inv Ther 1992;1:357–363.
5.
Shennib H, Bastawisy A, McLoughlin J, Moll F: Robotic computer–assisted telemanipulation enhances coronary artery bypass. J Thorac Cardiovasc Surg 1999;117:130–131.
6.
Loulmet D, Carpentier A, dÀttelis N, Berrebi A, Cardon C, Ponzio O, Aupècle B, Relland JYM: Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments. J Thorac Cardiovasc Surg 1999;118:4– 10.
7.
Mohr FW, Falk V, Diegeler A, Autschbach R: Computer–enhanced coronary artery surgery. J Thorac Cardiovasc Surg 1999;117:1212–1215.
8.
Cardière GB, Himpens J, Vertruyen M, Favretti F: The world’s first obesity surgery performed by a surgeon at a distance. Obes Surg 1999;9:206–209.
9.
Binder J, Kramer W: Robotically assisted laparoscopic radical prostatectomy. BJU Int 2001;87:408–410.
10.
Vallancien G: Pers. Commun.
11.
Abbou CC, Hoznek A, Salomon L, Lobontiu F, Saint F, Cicco A, Antiphon P, Chopin D: Prostatectomie radicale laparoscopique réalisée à distance par robot. A propos d’un cas. Prog Urol 2000;10:520–523.
12.
Rassweiler J, Sentker L, Seemann O, El–Quaran M, Stock C, Frede T: Laparoscopic radical prostatectomy: Technique and first experiences (Engl. abstract). Akt Urol 2000;31: 238–247.
13.
Rassweiler J, Sentker L, Seemann O, Hatzinger M, Stock C, Frede T: The Heilbronn laparoscopic radical prostatectomy: Technique and results after 100 cases. Eur Urol, in press.
14.
Breedveld P, Stassen HG, Meijer DW, Stassen LPS: Theoretical background and conceptual solution for depth perception and eye–hand coordination problems in laparoscopic surgery. Min Invas Ther Allied Technol 1999;8:227– 234.
15.
Schurr MO, Kunert W, Arezzo A, Buess G: The role and future of endoscopic imaging systems. Endoscopy 1999;71:557–562.
16.
Pietrabissa A, Scarcello E, Carobbi A, Mosca F: Three dimensional versus two–dimensional video system for the trained endoscopic surgeon and the beginner. Endoscop Surg 1994;2: 315–317.
17.
Lirici MM, Papaspyropoulos V, Angelini L: Telerobotics in medicine and surgery. Min Invas Ther Allied Technol 1997;6:364–378.
18.
Schurr MO, Buess G, Rinisland H, Holler E, Niesius B, Voges U: Artemis: Manipulatorsystem für die endoskopische Chirurgie. Endosk Heute 1996;9:245–251.
19.
Begin E, Gagner M, Hurteau R, de Santis S, Pomp A: A robotic camera for laparoscopic surgery: Conception and experimental results. Surg Laparosc Endosc 1995;5:6–11.
20.
Garcia–Ruiz A, Smedira NG, Loop FD, Hahn JF, Miller JH, Steiner CP, Gagner M: Robotic surgical instruments for dexterity enhancement in thorascopic coronary artery bypass graft. J Laparendosc Adv Surg Tech 1997;7:277–283.
21.
Reichenspurner H, Damiano R, Mack M, Boehm D, Gulbins H, Detter C: Use of the voice–controlled surgical system ZEUS for endoscopic coronary bypass grafting. J Thorac Cardiovasc Surg 1999;118:11–16.
22.
Sung GT, Gill IS, Meraney AM, Hsu TH: Telepresent robotic laparoscopic nephrectomy and adrenalectomy: The initial feasability study (abstract 33). J Urol 2000;163:8.
23.
Falk V, Gummert JF, Walther T, Hayase M, Berry GJ, Mohr FW: Quality of computer enhanced totally endoscopic coronary bypass graft anastomosis: Comparison to conventional technique. Eur J Cardiothorac Surg 1999; 13:260–266.
24.
Falk V, McLoughlin J, Guthart G, Salisbury JK, Walther T, Gummert J, Mohr FW: Dexterity enhancement in endoscopic surgery by a computer–controlled mechanical wrist. Min Invas Ther Allied Technol 1999;8:235–242.
25.
Autschbach R, Falk V, Stein H, Mohr FW: Experience with a new OR dedicated to robotic surgery. Min Invas Ther Allied Technol 2000; 9:213–217.
26.
Schurr MO, Buess GF: Systems technology in the operating theatre: A prerequisite for the use of advanced devices in surgery. Min Invas Ther Allied Technol 2000;9:179–184.
27.
Rassweiler J, Henkel TO, Köhrmann KU, Potempa D, Jünemann KP, Alken P: Lithotripter technology: Present and future. J Endourol 1992;6:1–13.
28.
Janetschek G, Rassweiler J: Future outlook; in Janatschek G, Rassweiler J, Griffith D (eds): Laparoscopic Surgery in Urology. Stuttgart, Thieme, 1996, pp 276–280.
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.